Clinical Trial

Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population

Withdrawn
View on ClinicalTrials.gov →
Why the trial stopped
The study did not start, i.e., no participants were enrolled, because the Mexican Regulatory Authority (COFEPRIS) did not authorize the amendments to the protocol.
Summary
This study compares the efficacy of cytology (Pap smear) with the molecular screening in their ability to detect reactive cellular changes in the cervix among an open population
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-29.
Status change: Not Yet Recruiting → Withdrawn 2026-02-27
Trial Details
NCT Number NCT07211204
Lead Sponsor Timser SAPI de CV
Conditions Atypical Squamous Cell of Undetermined Significance, ASC-US, Atypical Glandular Cells of Uncertain Significance, AGUS, Cervical Intraepithelial Neoplasia (CIN), CIN 1, CIN 2, CIN 3 +1 more
Start Date 2026-02-27
Primary Completion 2026-02-27 (estimated)
Study Completion 2026-02-27 (estimated)
Updated on ClinicalTrials.gov 2026-03-03